Victory Capital Management Inc. Purchases 8,101 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Victory Capital Management Inc. boosted its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 5.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 149,246 shares of the medical instruments supplier's stock after buying an additional 8,101 shares during the period. Victory Capital Management Inc. owned approximately 0.61% of ICU Medical worth $20,724,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Quarry LP raised its holdings in ICU Medical by 764.3% during the fourth quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock worth $38,000 after buying an additional 214 shares during the last quarter. Murphy & Mullick Capital Management Corp bought a new stake in shares of ICU Medical in the 4th quarter worth $52,000. Russell Investments Group Ltd. grew its stake in shares of ICU Medical by 88.8% in the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock worth $99,000 after acquiring an additional 300 shares in the last quarter. Sterling Capital Management LLC grew its stake in shares of ICU Medical by 813.5% in the 4th quarter. Sterling Capital Management LLC now owns 676 shares of the medical instruments supplier's stock worth $105,000 after acquiring an additional 602 shares in the last quarter. Finally, GAMMA Investing LLC grew its stake in shares of ICU Medical by 27.2% in the 1st quarter. GAMMA Investing LLC now owns 716 shares of the medical instruments supplier's stock worth $99,000 after acquiring an additional 153 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on ICUI. Wall Street Zen upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research note on Sunday, May 18th. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. KeyCorp reduced their target price on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Finally, Raymond James Financial reduced their target price on shares of ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating for the company in a research note on Friday, May 9th. One analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $192.67.

ICU Medical Stock Performance

NASDAQ ICUI traded up $0.71 during trading hours on Friday, reaching $129.90. 109,564 shares of the company were exchanged, compared to its average volume of 223,989. ICU Medical, Inc. has a 1 year low of $117.92 and a 1 year high of $196.26. The business's 50 day simple moving average is $131.18 and its 200-day simple moving average is $142.72. The company has a quick ratio of 1.52, a current ratio of 2.59 and a debt-to-equity ratio of 0.75. The stock has a market capitalization of $3.20 billion, a P/E ratio of -33.92 and a beta of 0.87.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.23 by $0.49. ICU Medical had a negative net margin of 3.87% and a positive return on equity of 6.75%. The business had revenue of $599.49 million during the quarter, compared to the consensus estimate of $574.15 million. During the same quarter last year, the company posted $0.96 earnings per share. The firm's quarterly revenue was up 6.7% compared to the same quarter last year. On average, equities research analysts expect that ICU Medical, Inc. will post 4.11 earnings per share for the current year.

Insider Activity at ICU Medical

In related news, COO Christian B. Voigtlander sold 4,985 shares of the firm's stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $128.50, for a total transaction of $640,572.50. Following the completion of the sale, the chief operating officer owned 6,088 shares in the company, valued at approximately $782,308. This trade represents a 45.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Ben Sousa sold 2,000 shares of ICU Medical stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $137.36, for a total transaction of $274,720.00. Following the completion of the transaction, the insider owned 479 shares of the company's stock, valued at $65,795.44. The trade was a 80.68% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 36,097 shares of company stock worth $4,860,156. 1.50% of the stock is currently owned by corporate insiders.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.